Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04062851 · ClinicalTrials.gov registry record · NA
Routine Versus no Assessment of Gastric Residual Volumes in Preterm Infants
A NA study, sponsored by AdventHealth.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT04062851: Completed NA study, sponsored by AdventHealth.
NCT04062851 is a NA study that has completed, run by AdventHealth. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04062851, a NA study, has completed, sponsored by AdventHealth.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
The practice of checking gastric residuals is not evidence based. The amount of gastric residual volume (GRV) does not correlate with either feeding intolerance or development of NEC. We hypothesize that not monitoring GRV in infants with birth weights \< 1,250 g, and who are being fed intermittently by gastric tube, will result in earlier attainment of full feeding. This is an unblinded randomized controlled trial where GRV will not be checked routinely in the intervention group.
Primary Outcome
Days to reach enteral feeding volume of 120ml/kg/day
Interventions
- OTHER No Gastric residual volume monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2019-05-03 |
| Est. Completion | 2022-03-31 |
| Phase | NA |
What the finished NCT04062851 record still lists
NCT04062851 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which No Gastric residual volume monitoring is the first listed.
NCT04062851 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04062851 about?
NCT04062851 is a clinical study titled "Routine Versus no Assessment of Gastric Residual Volumes in Preterm Infants". The practice of checking gastric residuals is not evidence based. The amount of gastric residual volume (GRV) does not correlate with either feeding intolerance or development of NEC. We hypothesize that not monitoring GRV in infants with birth weights \< 1,250 g, and who are being fed intermittentl...
What is the current status of trial NCT04062851?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2019-05-03. Estimated completion is 2022-03-31.
What interventions are being tested in trial NCT04062851?
The interventions under investigation include: No Gastric residual volume monitoring (OTHER).
Who is sponsoring clinical trial NCT04062851?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04062851's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI